Companies / BOC Sciences / Fasinumab
BOC Sciences

Fasinumab | BOC Sciences

Fasinumab is a human monoclonal antibody to nerve growth factor (NGF). Fasinumab has been undergoing clinical trials for the treatment of osteoarthritis (OA) hip and/or knee pain.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.